As science-based organizations look to leverage the internet of things (IoT) within the laboratory, careful consideration must be given to available technologies, data formats, and platforms.
Finite Element Analysis (FEA) has been widely used to analyze the in vivo structural response of implantable medical devices and assess device performance, reliability and durability. In order to obtain a robust design, parameter variations and their influence on device performance need to be understood. Probabilistic analysis techniques like Monte Carlo sampling combined with FEA clarify these stochastic processes and in determining probability of failure and design reliability. In this study, FEA using Abaqus is combined with statistical and probabilistic analysis using Isight to demonstrate how these techniques work together to evaluate the robustness of medical device designs.
Vascular stents are deployed in the blocked arteries to restore the passage of the blood flow. Conventional design analysis procedure wouldn’t be able to tackle simultaneously the problems of recoil and foreshortening, and often its time consuming. This paper discusses the use of such advanced technique to solve the stent design problems, and covers the essence of Finite Element Analysis, FE Model Parameterization and Optimization.
This white paper explores best practices in SaaS selection and incorporation into laboratory practices that enable organizations to focus on their core competencies while utilizing best-of-breed software.
Filtration and separation technologies are the core of water treatment processes, and in many cases, they can be critical process bottlenecks.
Biotech Millennium found that by clearly defining workflows and implementing a highly configurable notebook, it could move its entire discovery organization to a single ELN system.
A guide selecting the most relevant environmental parameters to study to retrieve the most useful information from collected samples.
Continued Process Verification (CPV), Process Analytical Technology (PAT) and Quality by Design (QbD), are driving pharma to improve product and process quality and efficiency.
CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part of CAP’s Accreditation Programs. The CAP accreditation – and the Clinical Laboratory Improvement Amendments (CLIA) certification that CIRCULOGENE achieved in 2015 – are internationally recognized credentials awarded to laboratories complying with the most comprehensive, rigorous and scientifically-endorsed standards of laboratory practice. “This